article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. percent in 2022.

Packaging 118
article thumbnail

Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox

Outsourcing Pharma

Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. Downstream Activities (Scope 3) Lonza has designed optimised distribution networks to reduce transport distances to customers, ensuring efficient logistics with a lower carbon footprint.

Dosage 104
article thumbnail

USP General Chapter —Glass revised

European Pharmaceutical Review

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105
article thumbnail

STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more

STAT

This calls for celebration with a cup of stimulation, and we are opening a new package of pecan pie for the occasion. In a press release issued ahead of an investor meeting today, the company also said it plans to break even by 2028, when it expects it will reach annual sales of $6 billion. Sound familiar?

Packaging 137
article thumbnail

Future-proofing the pharma cold chain

Express Pharma

billion by 2028, exhibiting a CAGR of 13.1 per cent during 2022-2028. This has presented an ongoing market opportunity for packaging providers to develop and deliver cutting-edge packaging solutions that ensure product integrity, regulatory compliance, and patient safety. billion in 2022.

Packaging 115
article thumbnail

Novo Nordisk to expand French production facilities

European Pharmaceutical Review

These activities are expected to be completed incrementally between 2026 to 2028, the company stated. Novo Nordisk declared that it will help to boost its global capacity, “from manufacturing of active pharmaceutical ingredients (API) through to packaging.” Construction has already begun.